Резултати
eNauka >
Results >
Early analysis of immunotherapy safety and benefit in metastatic/recurrent/persistent cervical cancer treated with first-line pembrolizumab: a tertiary centre experience
| Title: | Early analysis of immunotherapy safety and benefit in metastatic/recurrent/persistent cervical cancer treated with first-line pembrolizumab: a tertiary centre experience | Authors: | Kutic, Slobodan; Bobic, Simonida   ; Pavlovic, Lidija; Matovic, Milana ; Mijucic, Jovana; Milovic-Kovacevic, Marijana |
Issue Date: | 2026 | Publication: | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. ESGO 2026 Congress 26 February 2026 - 28 February 2026 | ISSN: | 1048-891X International Journal of Gynecological Cancer Search Idenfier |
Publisher: | IGCS ESGO Wiley |
Type: | Conference Paper | Collation: | vol. 36 br. 2 str. 103269-103269 | DOI: | 10.1016/j.ijgc.2025.103269 | WoS-ID: | 001715932700085 | URI: | https://enauka.gov.rs/handle/123456789/1035979 | URL: | https://www.international-journal-of-gynecological-cancer.com/article/S1048-891X(25)02393-X/abstract | Metadata source: | (Preuzeto iz Nasi u WoS) | Availability note: | Пуни текст није јавно доступан | M-category: | Mp. category will be shown later |
Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.